New op-ed published by leaders from the Women’s Alzheimer’s Movement at Cleveland Clinic, Alzheimer’s Research UK and the ...

The phrase "patient-centered care" is tossed around freely in healthcare corporate boardrooms. Yet, for more than half the ...

As clinical trials accelerate, clear, accessible consent is essential to help participants understand, engage with and remain ...

AstraZeneca has entered into an exclusive licence agreement with Dizal Pharmaceutical for Zegfrovy (sunvozertinib), a novel ...

Cherry, a full-service creative healthcare agency, has appointed Peter Henshaw as Managing Director. Henshaw will be ...

The unique combination of technology marks 25 years of industry innovation and expertise, and signals company’s next phase of ...

Bristol Myers Squibb’s New Drug Application (NDA) for mezigdomide has been accepted by the US FDA. Mezigdomide is an oral ...

Exonate has appointed Olav Hellebø as Chief Executive Officer (CEO). Hellebø brings extensive business and scientific ...

Boehringer Ingelheim’s Jascayd (nerandomilast) tablets have been granted marketing authorisation by the Medicines and ...

Ipsen is set to acquire Memo Therapeutics in a deal worth more than €700m EUR that is focused on potravitug, a phase 2 ...

Teva Pharmaceutical has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) seeking approval ...

Alignment is not proven by whether teams are coordinated, it is proven by whether their combined efforts are sustained ...